Invesco Ltd. - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 84 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$974,000
-31.0%
18,444
-20.0%
0.00%
-100.0%
Q2 2020$1,412,000
+8.8%
23,046
+0.4%
0.00%0.0%
Q1 2020$1,298,000
+7.0%
22,944
+7.8%
0.00%
Q4 2019$1,213,000
+5.9%
21,290
-0.4%
0.00%
Q3 2019$1,145,000
+11.5%
21,378
+24.2%
0.00%
Q2 2019$1,027,000
-28.5%
17,216
-25.2%
0.00%
Q1 2019$1,436,000
-0.7%
23,027
-3.5%
0.00%
-100.0%
Q4 2018$1,446,000
-4.0%
23,866
-7.3%
0.00%
Q3 2018$1,506,000
+42.7%
25,742
+9.4%
0.00%
Q2 2018$1,055,000
+12.2%
23,535
+10.9%
0.00%
Q1 2018$940,000
-46.3%
21,215
-47.5%
0.00%
-100.0%
Q4 2017$1,751,000
-28.5%
40,408
-23.3%
0.00%0.0%
Q3 2017$2,450,000
-6.5%
52,690
-0.5%
0.00%0.0%
Q2 2017$2,621,000
-13.6%
52,938
-4.4%
0.00%0.0%
Q1 2017$3,035,000
-4.7%
55,397
-3.1%
0.00%0.0%
Q4 2016$3,185,000
+18.4%
57,178
-2.9%
0.00%0.0%
Q3 2016$2,689,000
+31.0%
58,876
+14.5%
0.00%0.0%
Q2 2016$2,053,000
+33.2%
51,435
+16.3%
0.00%0.0%
Q1 2016$1,541,000
-53.6%
44,230
-42.8%
0.00%0.0%
Q4 2015$3,322,000
+6.7%
77,304
+8.1%
0.00%0.0%
Q3 2015$3,114,000
-7.1%
71,498
+10.0%
0.00%0.0%
Q2 2015$3,353,000
+85.7%
64,969
+40.8%
0.00%0.0%
Q1 2015$1,806,000
+36.0%
46,150
+34.2%
0.00%0.0%
Q4 2014$1,328,000
+16.5%
34,390
+6.5%
0.00%
Q3 2014$1,140,000
+472.9%
32,300
+339.5%
0.00%
Q2 2014$199,0007,3500.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q4 2014
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 385,954$16,723,00010.02%
JW Asset Management, LLC 73,649$3,191,0003.40%
Elk Creek Partners, LLC 168,714$7,310,0000.43%
NORTHPOINTE CAPITAL LLC 80,710$3,497,0000.39%
Ativo Capital Management LLC 33,096$1,434,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 155,318$6,730,0000.26%
ISTHMUS PARTNERS, LLC 17,406$754,0000.20%
Matarin Capital Management, LLC 48,952$2,121,090,0000.16%
GLOBEFLEX CAPITAL L P 4,324$187,0000.05%
Summit Trail Advisors, LLC 6,797$295,0000.04%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders